APPETE INTAKE: A Study on the Effects of Adding an Appetite Engine to a Nutritional Drink (APPETE INTAKE)

September 28, 2026 updated by: Nutricia Research

Effects of Adding an Appetite Engine to an Oral Nutritional Supplement (ONS) on Dietary Intake in Older Adults in Need of Additional Nutritional Support

The aim of this study is to investigate the effect of adding an appetite engine to a high-protein oral nutritional supplement (ONS) on acute dietary intake in older adults.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Krakow, Poland
        • Novamedpharm
        • Contact:
          • Dr. Nowak
        • Principal Investigator:
          • Dr. Nowak

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Adults aged 65 years or older Older adults in need of additional nutritional support, such as those currently using oral nutritional supplements or identified as malnourished or at risk of malnutrition Able to consume oral nutritional drinks as part of daily nutrition Able and willing to provide written informed consent

Exclusion Criteria:

Medical conditions that significantly affect food intake, digestion, or gastrointestinal function Conditions or treatments known to markedly influence appetite or nutritional intake Known allergies or intolerances to components of the nutritional drinks Use of tube feeding or parenteral nutrition Participation in another interventional study during the study period Any condition that, in the investigator's opinion, could interfere with study participation or compliance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Test ONS with appetite engine

ONS containing appetite engine

Nutritional drink consumed twice daily

Active Comparator: Control ONS

ONS without appetite engine

Oral nutritional drink consumed twice daily

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acute dietary intake
Time Frame: Assessed on Day 1 of each intervention period.

Amount of energy consumed during a single meal after intake of a nutritional drink.

Assessed on Day 1 of each intervention period.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satiety and appetite responses
Time Frame: From before intake up to 120 minutes after intake of the nutritional drink on Day 1 of each intervention period.

Participant-reported feelings related to hunger and fullness assessed using standardized questionnaires.

From before intake up to 120 minutes after intake of the nutritional drink on Day 1 of each intervention period.
Product adherence
Time Frame: Assessed daily during each intervention period (up to 7 days).

Compliance with consumption of the assigned nutritional drink.

Assessed daily during each intervention period (up to 7 days).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 15, 2026

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

August 18, 2026

First Submitted That Met QC Criteria

September 28, 2026

First Posted (Actual)

October 5, 2026

Study Record Updates

Last Update Posted (Actual)

October 5, 2026

Last Update Submitted That Met QC Criteria

September 28, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 24REX0063742

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.